[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Important article even if not radiation related



The following appeared in today's Washington Post. 

The implications regarding the setting of regulatory

limits may be influenced not only for the use of

chemicals and pesticides, but may have implication for

ALARA decision making.



------------------------------------ 

 Pesticide Testing on Humans  Is Ethical, Science

Panel Says

 

 By Shankar Vedantam

 

  It is ethical to test pesticides and pollutants on

human volunteers in order to determine whether

environmental safety standards can be lowered, a top

panel of scientists said yesterday in an opinion that

is expected to strongly influence government policy.

 

 Many scientists and ethicists have argued that such

research is never justified, and yesterday's

unprecedented verdict by the National Academy of

Sciences took environmentalists by surprise.

 

 The pesticide industry has vehemently supported such

tests for years, arguing that current regulatory

limits on exposure to environmental toxins are overly

cautious. Manufacturers of pesticides and companies

that produce pollutants say human studies will

demonstrate that higher levels of toxins in the air

and water are not harmful.

 

 While volunteers would derive no benefit and some

might incur transient harm, the panel of experts said

this would be outweighed by societal benefits. Besides

helping regulators set accurate benchmarks for

environmental dangers, such trials might also address,

for example, how much insecticide can safely be used

to fight a malaria outbreak.

 

 Yesterday's decision by a panel of the National

Research Council will allow the Environmental

Protection Agency to devise a final rule over the next

several months, an EPA spokesman said. Both the

pesticide industry and environmental groups said they

expect the agency will accept the recommendation of

the panel, which would also allow the EPA  to evaluate

human studies of pesticides that had previously been

conducted, and give the industry an incentive to

conduct new trials.

 

 The panelists called for a rigorous safety and ethics

system to evaluate and approve such trials, much like

the system used by the Food and Drug Administration to

evaluate drug trials conducted by the pharmaceutical

industry.

 

 While there was no "foolproof mechanism" to eliminate

all risk of patient harm, the joint chairman of the

panel, James Childress, an ethics professor at the

University of Virginia, said that the risk for

volunteers would generally be "exceedingly low."

 

 Environmental groups acknowledged that the panel had

tried to institute safeguards, but feared that trials

would still cause harm.

 

 Currently, to determine what level of a toxin is safe

for human exposure, regulators at the EPA first

determine what dose is toxic to animals. Regulators

divide that dose by 10, because humans may react more

sensitively than animals -- called the "inter-species

safety factor." Because  some people are more

sensitive than others, regulators lower the

potentially toxic dose by another factor of 10.

Finally, to protect children and fetuses, a third

safety factor of as much as 10 is introduced.

Collectively, these safety factors can reduce human

exposure limits to toxins to one-thousandth the dose

that harms animals.

 

 The goal of human pesticide studies is to lower the

inter-species factor. If companies can show that

humans are not more sensitive than rats, higher

exposure levels might be permitted.

 

 Richard Wiles, senior vice president at the

Environmental Working Group, an advocacy organization,

said that while the EPA can enforce a tenfold safety

factor to protect children, it does not do so for many

chemicals. As a result, he said, the exposure limit

for humans might end up being only one-tenth the toxic

animal dose.

 

 "Pesticide law would have gone from the toughest law

on the books to the weakest law on the books through

this marvelous sleight of hand that the industry has

pulled," Wiles said.

 

 The report allowed for the possibility of trials

involving children, but panelists said they could not

imagine such tests would ever be conducted. But Erik

Olson, senior attorney at the Natural Resources

Defense Council, an environmental group, said such

tests have already been performed: As recently as

2000, he said, a manufacturer petitioned the EPA to

consider data from an Italian study of infants that

deliberately exposed them to dichlorvos, an

insecticide sold under the brand name Vapona.

 

 Dichlorvos manufacturer Amvac Chemical Corp., of

Newport Beach, Calif., petitioned the agency to

consider two 1969 trials titled "Exposure of Newborn

Babies to Vapona Insecticide" and "Clinical Effects of

Exposure to DDVP (Vapona) Insecticide in Hospital

Wards." 

 

 A call to Amvac  was returned by consultant Howard

Berman, president of Environmental Mediation Inc.

Berman said that the trials cited in the petition had

not been commissioned by Amvac. Speaking on behalf of

the company, he said Amvac  had no plans to conduct

trials among children. 

 

 Jay Vroom, president of Croplife America, which

represents pesticide manufacturers, said he knew of no

company that planned to test pesticides on children.

 

 But data from adult trials would be useless in

predicting the risk for children, said Philip

Landrigan, a Mount Sinai pediatrician in New York and

chairman of a National Academy of Sciences panel in

1993 that examined the risk of pesticides on children.

 

 During the  Clinton administration, the  EPA refused

to consider any human trials. The Bush administration

reopened the possibility of using the tests.

 

 The pesticide industry dismissed critics of the

trials as biased, and environmental groups countered

yesterday with similar criticism of the NRC panel.

Olson, the NRDC attorney, produced documentation that

panel member James Bruckner, a professor of

pharmacology and toxicology at the University of

Georgia, was a paid expert witness for Lockheed Martin

Corp., which is fighting a lawsuit in California over

whether pollution from its products might have caused

cancer and thyroid problems.

 

 Gail Rymer, a spokeswoman for Lockheed Martin in

Bethesda, confirmed that the company had paid for a

human study of a rocket fuel component called

perchlorate in hopes of influencing the California

lawsuit. 

 

 Bruckner and the National Academy of Sciences said

there was no conflict of interest because he testified

as an expert on a chemical called trichloroethylene

and did not know about the perchlorate study. 

 

 Olson and Gary Praglin, who is suing Lockheed Martin

on behalf of alleged victims in Redlands, Calif., said

the argument was specious.

 

    

Would you like to send this article to a friend? Go to



http://www.washingtonpost.com/ac2/wp-dyn/admin/emailfriend?contentId=A56062-2004Feb19&sent=no&referrer=emailarticle

 

(c) 2004 The Washington Post Company





=====

+++++++++++++++++++

"The care of human life and happiness . . . is the first and only legitimate object of good government."

Thomas Jefferson



-- John

John Jacobus, MS

Certified Health Physicist

e-mail:  crispy_bird@yahoo.com



__________________________________

Do you Yahoo!?

Yahoo! Mail SpamGuard - Read only the mail you want.

http://antispam.yahoo.com/tools

************************************************************************

You are currently subscribed to the Radsafe mailing list. To

unsubscribe, send an e-mail to Majordomo@list.vanderbilt.edu  Put the

text "unsubscribe radsafe" (no quote marks) in the body of the e-mail,

with no subject line. You can view the Radsafe archives at

http://www.vanderbilt.edu/radsafe/